Tim J.
- Country
- The Netherlands
- Department
- Rheumatology
Research Overview
Data & Insights
Has run more than one trial at 0 of 8 partner sites.
Specializations
Cardiovascular Disease and Lipid Management
The investigator concentrates on conditions such as atherosclerotic cardiovascular disease, acute coronary syndromes, and peripheral arterial disease, emphasizing risk reduction and outcome improvement.
- Major adverse cardiovascular events (MACE) prevention
- Lipoprotein(a) lowering strategies
- Antithrombotic therapy optimization
- Heart failure risk mitigation
Research integrates biomarkers, imaging, and patient‑centered endpoints to advance cardiovascular care.
Oncology and Targeted Cancer Therapies
Focused on a broad spectrum of malignancies, including breast cancer, colorectal cancer, prostate cancer, and hematologic neoplasms, the investigator explores innovative therapeutic combinations.
- HER2‑positive disease management
- Hormone‑receptor positive breast cancer strategies
- Advanced solid tumor precision medicine
- Novel agents for metastatic prostate cancer
Efforts aim to improve survival and quality of life across cancer types.
Autoimmune and Inflammatory Rheumatology
Within the rheumatology specialty, the investigator addresses diseases such as psoriatic arthritis, gout, and systemic inflammatory conditions.
- Biologic and small‑molecule therapies for arthritis
- Gout flare management
- Biomarker‑driven treatment selection
- Patient‑reported outcome integration
Research seeks to balance efficacy with safety in chronic inflammatory disorders.
Metabolic and Renal Disorders
The investigator’s work includes type 2 diabetes, chronic kidney disease, and hypertension, targeting disease progression and organ protection.
- Glucose‑lowering agents with cardiovascular benefit
- Renal outcome preservation in advanced CKD
- Blood pressure control in high‑risk populations
- Integration of metabolic risk markers
Studies emphasize multidisciplinary approaches to metabolic health.
Neurology and Rare Hematologic Malignancies
Investigations extend to neurological emergencies and rare blood cancers, including status epilepticus after cardiac arrest and diffuse large B‑cell lymphoma.
- Neuroprotective strategies post‑cardiac arrest
- Targeted therapies for aggressive lymphomas
- Genomic profiling to guide treatment
- Outcome measures for acute neurological events
These efforts aim to enhance survival and functional recovery.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.